Submission Criteria for ASMF Interested Parties meeting with Joint Working Group on ASMF Procedures Dr Paul Marshall Chair of the Joint Working Group on ASMF Procedures

Source URL: www.hma.eu

• Biologic
• Impurity
• Science
• Pharmaceutical industry
• Technology
• Application programming interface
• Technical communication
• Chemical substance

CMDh meeting with Interested Parties[removed]ASMF Worksharing Procedure On behalf of EFPIA: Mirella Franci and Keith Tomlin

Source URL: www.hma.eu

• European Federation of Pharmaceutical Industries and Associations
• Question
• Social psychology

EU/ASMF worksharing procedure Updates to EU/ASMFs Interested Parties meeting with Joint Working Group on ASMF Procedures Dr Paul Marshall Chair of the Joint Working Group on ASMF Procedures

Source URL: www.hma.eu

• Validation
• Validity
• European Union
• Political philosophy
• Science
• Sociology
• Pharmaceutical industry
• Clinical research
• Quality

Update on the EU ASMF assessment worksharing procedure Interested Parties meeting with Joint Working Group on ASMF Procedures Dr Paul Marshall

Source URL: www.hma.eu

Doc. Ref: CMDh[removed]November 2013 Working Group on Active Substance Master File Procedures The work sharing procedure for the assessment of Active Substance Master File (ASMF)

Source URL: www.hma.eu

• Strasbourg
• European Medicines Agency
• Pharmaceutics
• Research
• Pharmaceutical sciences
• Pharmaceutical industry
• Council of Europe
• European Directorate for the Quality of Medicines

Microsoft PowerPoint - ASMF worksharing - Training PUBLIC v2 [Read-Only]

Source URL: www.hma.eu

Qualité nutritionnelle des mets servis au Camp de l’AMSF Par Pierrette Bergeron, dt.p., M.A. L’ASMF se soucie de l’intérêt des participants pour la qualité nutritionnelle des menus, en l’indiquant pour chaque

Source URL: www.amsfski.com

Joint WG on ASMF procedures Worksharing pilot phase Christa Wirthumer-Hoche Meeting with IPs May 2013

Source URL: www.hma.eu

• European Union
• Political philosophy
• Council of Europe
• European Directorate for the Quality of Medicines
• Strasbourg

Dear Sir/Madam, I have a comment on section - B.I Quality changes- B.I.a) Manufacture -Section g) "Introduction of New manufacturer of the active substance that is not supported by an ASMF and requires significant update

Source URL: ec.europa.eu

EMA/CMDV[removed] <> "Error*"EMA/CMDV[removed] \* MERGEFORMAT EMA/CMDV[removed]2013EMA/CMDV[removed] Page 1/1 Veterinary National Contact points providing EU/ASMF-number

Source URL: www.hma.eu